Cancer glossary
Carcinoma in situ (Tis, stage 0): what it means on your report
Carcinoma in situ means abnormal cells that have not grown beyond the epithelium. Why it is called stage 0, how it differs from invasive cancer, and how it is treated.
Written and medically reviewed by
Dr. Tara EinullaevaMedical oncologist, 9 years in practice. Credentials · reviewed 17 October 2026
In short
Carcinoma in situ means abnormal tumor cells that stay within the epithelium where they started and have not grown into surrounding tissue. In TNM it is recorded as Tis, and in stage groups it is stage 0.
How it appears in your report
- ‘Ductal carcinoma in situ (DCIS)’ — in the breast.
- ‘Squamous cell carcinoma in situ’, ‘intraepithelial carcinoma’.
- ‘pTis’ — the T category based on removed tissue; see TNM.
- ‘Invasive carcinoma with an in situ component’ — the tumor has both an invasive part and an in situ part. Treatment is then planned around the invasive part.
What it means
The key difference is the border of the epithelium. In situ cells have not crossed it; in invasive cancer they have, and can reach blood vessels and lymph nodes.
| Finding | What it is |
|---|---|
| Dysplasia | abnormal cells, not yet cancer; grading depends on the organ |
| Carcinoma in situ (Tis, stage 0) | tumor cells confined to the epithelium |
| Invasive cancer (T1 and above) | the tumor has grown beyond the epithelium |
The US National Cancer Institute describes stage 0 this way: abnormal cells are present but have not spread to nearby tissue; it is not cancer, but it may become cancer. For ductal carcinoma in situ, the American Cancer Society notes that, if untreated, it can sometimes become invasive cancer, and there is currently no reliable way to know in advance which cases will.
Does it affect treatment
Yes. In situ disease is usually treated locally: removing the area, sometimes followed by radiation. For ductal carcinoma in situ, hormone therapy may be discussed after surgery if the cells are hormone receptor-positive. The resection margin also matters: these tumors have their own standards for how wide a clear margin should be. Your treating doctor, and a tumor board if needed, makes the decision.
Questions to ask your doctor
- Is there an invasive component in the sample, or only in situ disease?
- If this was only a biopsy, was there enough tissue to rule out invasion?
- What are my treatment options, and is hormone therapy needed?
If the diagnosis sounds uncertain or does not fit with your other results, a second opinion makes sense.
Sources
- Cancer Staging — National Cancer Institute (NCI), 2022
- What Is Cancer? — National Cancer Institute (NCI), 2026
- Ductal Carcinoma In Situ (DCIS) — American Cancer Society, 2026
FAQ
Related terms
This is reference information and not a substitute for medical advice. Your doctor interprets each value in the context of your whole situation.
